Recent Progress of Src Family Kinase Inhibitors as Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|8|10|1053-1063

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.10, 2008-09, pp. : 1053-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 17, Iss. 12, 2010-04 ,pp. : 1117-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Current progress towards the development of tyrosine kinase inhibitors as anticancer agents

By Bridges A.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 279-292

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. : 18-31

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the discovery of Src kinase inhibitors

By Parang Keykavous   Sun Gongqin  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1183-1207

Informa Healthcare

Access to resources Recommend Favorite